https://charts.traderzeitung.de/phases/US24661P8077
string(1397) "{"isin":"US24661P8077","name":"Delcath Systems Inc","stock_id_xnas":12101061,"stock_id_xnys":null,"generated_at":"2026-07-21 03:48:00","days":[{"date":"2026-07-16","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":12.87,"close_at":"2026-07-16 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-17","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":12.82,"close_at":"2026-07-17 21:59:00","complete":true,"perf_pct":-0.3885},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":12.6,"close_at":"2026-07-20 21:59:00","complete":true,"perf_pct":-1.7161},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Delcath Systems Aktie News & Nachrichten
Trading-Room

Delcath Systems Aktie News & Nachrichten

[WKN: A2PT5P | Symbol: DCTH]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Delcath Systems Chart

Artikel aus der Redaktion der Trader-Zeitung

Delcath Systems

TOP-5-Kursziele der Analysten am 23.05.25

PVA TePla [DE0007461006]: Deutsche Bank nimmt Hochstufung von "Hold" auf "Buy" vor und erhöht massiv...

Delcath Systems mit Hepzato Kit einzigartig zur Behandlung von metastasiertem Leberkrebs positioniert - Craig-Hallum sieht 30 %-Chance!

Delcath Systems (DCTH)  hat sich als Medizintechnikunternehmen auf wirkungsvolle und regionale Chemotherapien...

TOP-5-Kursziele der Analysten am 17.10.24

Canaccord (16.10.24) Kursziel 21 USD (122 % Kurspotenzial) Delcath Systems Inc. [US24661P8077] ...

  • ‹
  • 1
  • ›
Delcath Systems Nachrichtenticker öffnen
MT Newswires 09.07.2026 14:45 Uhr

Delcath Systems dosiert ersten Patienten in Phase-2-Studie von Hepzato

08:44 AM EDT, 07/09/2026 (MT Newswires) -- Delcath Systems (DCTH) teilte am Donnerstag mit, dass der erste Patient in seiner globalen klinischen Studi

MT Newswires 26.05.2026 23:23 Uhr

Delcath Systems veröffentlicht zwei ASCO 2026 Abstracts zu vom Prüfarzt initiierten Studien im Fortschritt

05:23 PM EDT, 05/26/2026 (MT Newswires) -- Delcath Systems (DCTH) teilte am späten Dienstag mit, dass es am 21. Mai zwei Abstracts zu vom Prüfarzt ini